Live Breaking News & Updates on பங்குதாரர் மதிப்பு படைப்பு
Stay updated with breaking news from பங்குதாரர் மதிப்பு படைப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
); } The investment group CtW has spoken out against the terms of Activision Blizzard CEO Bobby Kotick s contract extension, arguing that a number of other unaddressed provisions more than make up for any pay lost in Kotick s recent 50 percent salary reduction and urging shareholders to vote against the package. Kotick himself regularly earns in the millions from his role as Activision Blizzard s CEO, earnings that often veer into controversy when, for example, the company opts to lay off hundreds of developers during years of record earnings. Even outside of the game industry, Kotick s pay, its relation to median salaries at Activision Blizzard, and shareholder opposition for his pay packages have landed him on lists like As You Sow s Most Overpaid CEOs multiple times. ....
Activision Blizzard CEO Agrees To Cut Huge Salary And Bonuses Following Industry Backlash Share: Activision Blizzard CEO Bobby Kotick has agreed to a major pay cut to both his base salary and bonuses following feedback from shareholders. Over the past few years, the stark contrast between Kotick s monumental earnings and the way in which Activision staff have been treated has caused more than its fair share of upset across the industry. Back in 2019, following what Kotick described as a year of record results , the company laid off a reported 800 members of staff while simultaneously offering its new CFO $15 million worth of awards. ....
VANCOUVER, BC, April 6, 2021 /CNW/ - CubicFarm® Systems Corp. ( TSXV: CUB) ( CubicFarms or the Company ), a local chain agricultural technology company, today announced the appointment of Thomas Liston as Vice President (VP) of Corporate Development. Thomas (Tom) Liston will provide CubicFarms with strategic business development and capital markets advisory services in his role as VP of Corporate Development. Liston is a technology investor, advisor, and a Chartered Financial Analyst® with over 20 years of experience in capital markets. He s the founder of Water Street Corp and currently serves on several boards of directors for public and private technology companies, and he has a strong track record of shareholder value creation in that capacity. He has served on the Board of Directors of WELL Health Technologies (TSX: WELL) since April 2018 and Tantalus Systems Holding Inc. (TSX.V: GRID) since January 2021. ....
Executing on Strategy; Delivering Consistent Sales and EBITDA Growth 2 +5% comparable sales growth on core Bed Bath & Beyond banner 1; + +94% digital comparable sales growth on core Bed Bath & Beyond banner; +77% digital comparable sales growth on total enterprise +11% comparable sales growth in Top 5 destination categories combined (as referred below), representing 2/3 of core Bed Bath & Beyond banner sales; Market share gains in destination Bed category, with improving trends in Bath and Kitchen categories +2.2 million approximate new online customers gained by core Bed Bath & Beyond banner during the fiscal 2020 third quarter; +7 million approximate new online customers year-to-date +340bps expansion in Gross Margin; +310bps expansion in Adjusted Gross Margin ....
Alkermes Announces Strategic Value Enhancement Plan and Continued Board Refreshment Reflecting Rigorous Expense Management, Expected Revenue Growth and Commitment to Shareholder Value Creation - - Announces Potential Monetization of Non-Core Assets and Reiterates Commitment to Exploring Strategic Collaborations Around ALKS 4230 - - Two New Independent Directors Appointed and Board Refreshment Program to Continue - - Alkermes to Host Investor Day in the First Quarter of 2021 to Update Investors on Plan Implementation and R&D Portfolio - DUBLIN, Dec. 10, 2020 /PRNewswire/ Alkermes plc (Nasdaq: ALKS) today announced a Value Enhancement Plan, or the Plan, designed to drive growth, improve operational and financial performance and enhance shareholder value, as the company continues to advance its mission of developing new medicines designed to have a real-world impact in the treatment of serious mental illness, addiction and cancer. The Plan includes a commitment ....